Point of care (PoC) Data Management Systems Market Growth Accelerated by Increasing Adoption of Real-Time Patient Data Management Systems

A health care professional or a nurse performs the test, analysis is performed, and lastly the results are recorded.

Tests include lateral flow immunochromatography, enzyme-linked immunosorbent assays (ELISA), and agglutination test.Strong expertise with attention to detail makes our market research reports stand apart, Request a Report sample @  https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=25535 The health care industry has witnessed a major change in the past few years due to emerging technological innovations including biosensors, lab-on-a-chip, smartphone apps, and other wearable devices, contributing to a closer connection with the patient- point-of care technologies due to which it is becoming a part of the transformational healthcare landscape.

Increase in geriatric population, rise in prevalence of cardiovascular and diabetic diseases, and increased health care awareness are the major drivers of the market.

Improved technology, lab automation to provide cheaper, accurate, and high quality results, and increased home care facilities with rapid and effective diagnostic results also contribute to the growth of the point-of care lipid testing market.

Rural locations with limited lab services and shortage of trained laboratory workers present an opportunity for new entrants in developing countries.Pre Book Point of Care (POC) Lipid Testing Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=25535=SBased on product type, the POC lipid testing market has been segmented into consumables and instruments.

In terms of application, the market has been segmented into hypertriglyceridemia, hyperlipoproteinemia, Tangier disease, hyperlipidemia, familial hypercholesterolemia, and others.

Global Point-of-Care Testing Market (POC) was valued US$ 14Bn in 2017 and is anticipated to reach US$ 30Bn by 2026 at a CAGR of about 10.0% during a forecast.

Based on product type point of care market is segmented into Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Haematology Testing, Blood Gas Testing & Others.

By End-User are segmented in Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals.

Geographically into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.The driving factor for the point of care market is due to Rising in usage of home-based glucose monitoring systems, Coagulation Monitoring, Infectious Diseases Testing, in trending Pregnancy And Fertility Testing, developing technology and innovative launching scheme and best offers to eventually reduce public and national spending on health, These devices are being highly used for the rapid diagnosis of disease conditions for the early detection and management of the disease are the factor of growth in point of care market.

High logistics costs and huge investment will be the restrains for point of care market.Global Point-of-Care (POC) Testing Market is segmented into by product, by Product Type, by End-user Type, and by geography.

In End, User segment Home Care will be fastest growing department due to Growing concern for early-stage disease detection and to avoid the occurrence of any chronic condition is expected to drive the remote monitoring and raise demand for rapid tests are a growth opportunity in the point-of-care testing market.For More Information Visit https://www.maximizemarketresearch.com/market-report/global-point-of-care-testing-market/15349/Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The global point-of-care molecular diagnostics market size is anticipated to reach USD 3.86 billion by 2024 expanding at a CAGR of 14.4%, according to a new report by Grand View Research, Inc.

Ongoing research & development to miniaturize molecular diagnostics testing that provides enhanced near patient testing with high accuracy and lesser turnaround times are major factors expected to reinforce the high growth potential for POC MDx products.Growing demand for CLIA tests that are, by definition, portable and safe enough to be used in non-laboratory settings such as pharmacy clinics, physician offices, and home-care settings, is expected to drive demand in the market over the forecast period.

Ongoing research and development is continually supported and funded by a number of major international entities including the governments of developed countries.Furthermore, a growing portfolio of point-of-care testing capabilities that, had initially been focused on screening, testing, and diagnosis of infectious diseases in low-income developing countries, has been developing at a rapid pace over the past decade to expand its potential market to a broader range of medical faculties.

Consequently, POC and molecular diagnosis tests are available and/or are under development for cardiology monitoring, oncology testing, and hematology testing.Recent advances in the development of microfluidics and genetic sequencing instrumentation pave the way for development of cost-effective, highly accurate and rapid testing platforms, which are able to be used as true POC systems.

This is a key factor that significantly contributes towards the favorably funded, high growth potential environment prevalent in the PoC molecular diagnostics market.Further key findings from the study suggest:Application of POC MDx tests for infectious diseases accounted for over 45% of market revenue in 2018 due to the presence of many major market entities with an extensive product portfolioGrowing burden of infectious diseases in both developing and developed countries is another factor responsible for the dominance of this segmentPCR-based POC tests is the largest revenue generating segment of the market in 2018.

Widespread usage of PCR-based techniques for molecular diagnosis and commercialization of POC real time PCR products have provided ample opportunities for segment growthNorth America was the largest region and accounted for 43.5% of the global revenue share due to the presence of technologically advanced medical framework, high R investments by governments and private organizations for the development of POC MDx testsKey companies in the market include Johnson & Johnson; Danaher Corp.; Cepheid, Inc.; Bio-Rad Laboratories, Inc.; bioMerieux; Becton, Dickinson and Company; F. Hoffmann-La Roche AG; Bayer HealthCare Pharmaceuticals LLC ; Alere, Inc.; (Abbott), and Abbott Laboratories 

Point of care (POC) diagnostic devices are used to acquire particular clinical information of patients in clinical as well as resource-limited settings.

These devices are widely used to obtain diagnostic results.

POC diagnostics include sample testing to facilitate rapid diagnosis and help decide the treatment plan accordingly.

POC diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease.

Moreover, it is cost-efficient and time-saving, as well as offers various benefits such as can be performed easily, prevent sample spillage, no necessity of skilled professionals, etc.Point of care (POC) diagnostic devices are also used to test cholesterol and glucose levels, test for drugs of abuse and infectious diseases, do electrolyte and enzyme analysis, and for pregnancy testing.

POC allows physicians to accurately achieve real-time, lab-quality diagnostic results within minutes rather than hours.Point of care (POC) diagnostic devices are used for the diagnosis and treatment of diseases and medical conditions in nursing and other health care settings.

The Global Point of Care (PoC) Diagnostics Market research report offers accurate insights for the growth prospects of the Point of Care (PoC) Diagnostics market in the forecast years 2020-2027.

The report is an all-inclusive study of the Point of Care (PoC) Diagnostics market that offers the readers a better view of the current and emerging market trends through a thorough analysis of the market size, growth trends, supply and demand ratio, market share, sales network and distribution channels, and other key elements.Furthermore, the report is furnished with the current market scenario with regards to the COVID-19 pandemic.

The global public health emergency has disrupted the lives of everyone across the globe.

It has also had a substantial impact on the Point of Care (PoC) Diagnostics  industry as global supply chains have been disrupted, and the financial scenario is tight.

The report assesses the initial and future impact of the pandemic on the market and its key segments to offer an accurate futuristic outlook for remuneration in a post-COVID-19 scenario.Get a sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1507Scope of the Market Report: The report offers a holistic overview of the Point of Care (PoC) Diagnostics industry that offers all the essential information.

The report is formulated by extensive primary and secondary research and backed by the verified data from industry experts and professionals.

New York, NY 13 May 2021: The global Point of Care (PoC) diagnostics market is expected to reach US$ 24.70 billion by 2028, according to a new study by Polaris Market Research.

The report “Point of Care (PoC) Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays); By End-Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory); By Product; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global Point of Care (PoC) diagnostics market is driven by continuous technological advancement in the form of miniaturization of devices, growing preference of patients towards home care, and consistent decline in prices due to inflow of innovative market players.

The growing prevalence of target diseases such as cancer, diabetes, cardiovascular diseases and infectious diseases is expected to drive Point of Care (PoC) diagnostics industry.

Cardiovascular diseases are one of the most fatal disorders and are the leading cause of death across the globe.

Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-sample Segment HighlightsGlucose testing segment accounted for the largest revenue share in 2020.